Supply Chain Intelligence

Scinai Immunotherapeutics Ltd. Supply Chain

SCNI supply chain intelligence for Scinai Immunotherapeutics Ltd.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.

SCNI ·Last updated 2026-07-30 · Interactive map →

Data compiled by Redley Lamar · ChainSifter Intelligence

1Suppliers
2Customers
2Debt Items
20Related Chains

Scinai Immunotherapeutics Ltd. Suppliers

TickerNameConfidenceEvidence
MLTX MoonLake Immunotherapeutics 72% Reciprocal relationship from MLTX graph: Reciprocal relationship from SCNI graph: Reciprocal relationship from MLTX graph: LK through Phase 3 development and regulatory approval will require us to ex…

Scinai Immunotherapeutics Ltd. Customers

TickerNameConfidenceEvidence
SNYNF Sanofi 72% e Israeli Ministry of Environmental Protection in order to verify compliance with relevant instructions and regulations. In addition, all of our laboratory personnel participate in instruction on the…
SNYNF Sanofi 72% Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCNI graph: Reciprocal relationship from SNYNF graph: Reciprocal relationship from SCNI graph: e Israeli Ministry of Environment…

Scinai Immunotherapeutics Ltd. Debt Obligations

InstrumentDescriptionConfidenceEvidence
SCNI-DEBT-12421 Warrants outstanding: 1638062 90% xbrl warrant detail from xbrl 2025-07-31.
SCNI-DEBT Debt stack $2.3M 90% Market cache reports total debt of $2.3M.

Scinai Immunotherapeutics Ltd. Acquisitions

No acquisitions on recordNo completed or pending acquisitions found in our database for Scinai Immunotherapeutics Ltd..

Scinai Immunotherapeutics Ltd. Ownership

HolderNameConfidenceEvidence
SCNI-OWNER-CITADEL-ADVISORS-LLC Citadel Advisors Llc 95% 13F/ownership overlay lists Citadel Advisors Llc; shares held 34,562; ownership 0.98%; value $25,472; as of 2025-12-31.
SCNI-OWNER-MORGAN-STANLEY Morgan Stanley 95% 13F/ownership overlay lists Morgan Stanley; shares held 58; value $42; as of 2025-12-31.
SCNI-OWNER-VIRTU-FINANCIAL-LLC Virtu Financial LLC 95% 13F/ownership overlay lists Virtu Financial LLC; shares held 15,409; ownership 0.44%; value $11,356; as of 2025-12-31.
SCNI-OWNER-XTX-TOPCO-LTD Xtx Topco Ltd 95% 13F/ownership overlay lists Xtx Topco Ltd; shares held 27,294; ownership 0.77%; value $20,115; as of 2025-12-31.
SCNI-OWNER-RHUMBLINE-ADVISERS Rhumbline Advisers 95% 13F/ownership overlay lists Rhumbline Advisers; shares held 1,878; ownership 0.05%; value $1,384; as of 2025-12-31.
SCNI-OWNER-UBS-GROUP-AG UBS Group AG 95% 13F/ownership overlay lists UBS Group AG; shares held 1,748; ownership 0.05%; value $1,288; as of 2025-12-31.
SCNI-OWNER-NORTHWESTERN-MUTUAL-WEALTH-MANAGEMENT-CO Northwestern Mutual Wealth Management Company 95% 13F/ownership overlay lists Northwestern Mutual Wealth Management Company; shares held 1,000; ownership 0.03%; value $736; as of 2025-12-31.

Scinai Immunotherapeutics Ltd. Extended Supply Chain Network

TickerNameChain IndexHopsRelationship Types
REGN Regeneron Pharmaceuticals, Inc. 100.00 2
SVA Sinovac Biotech Ltd. 100.00 2
BLRX BioLineRx Ltd. 100.00 2
ATOS Atossa Therapeutics, Inc. 100.00 2
CALC CalciMedica, Inc. 100.00 2
ANRO Alto Neuroscience, Inc. 100.00 2
WHWK Whitehawk Therapeutics, Inc. 100.00 2
BIOA BioAge Labs, Inc. 100.00 2
CTMX CytomX Therapeutics, Inc. 100.00 2
CBIO Crescent Biopharma, Inc. 100.00 2
ANL Adlai Nortye Ltd. 100.00 2
ALXO ALX Oncology Holdings Inc. 100.00 2
CCEP Coca-Cola Europacific Partners PLC 100.00 2
DSGN Design Therapeutics, Inc. 100.00 2
AZN AstraZeneca PLC 100.00 2
CYTOF Altamira Therapeutics Ltd. 100.00 2
DBVTF DBV TECHNOLOGIES 100.00 2
EDIT Editas Medicine, Inc. 100.00 2
CYTK Cytokinetics, Incorporated 100.00 2
GRDX GridAI Technologies Corp. 100.00 2
View SCNI supply chain intel →

Explore the full interactive supply chain map for Scinai Immunotherapeutics Ltd..

Open SCNI supply chain map →
ChainSifter · Guerilla Finance Terms Disclaimer ← Back to Map